To Predict Weight Loss Response to Liraglutide (Saxenda®), from fMRI-based Determination of Food Cue Reactivity

Project Details

StatusActive
Effective start/end date06/1/18 → …

Funding

  • Novo Nordisk-Private: $481,321.00